No Action Letter for Acuity Brands, Inc. Advised Against Exclusion of Dividend Proposal Kirstyn JacobsJanuary 23, 2017
In re Biogen: United States District Court Dismisses Fraud Class Action Claims Against Biogen Inc. – Part II Matthew KilbyNovember 18, 2016
No-Action Letter for Cardinal Health, Inc. Allowed Exclusion of Proxy Access Bylaw Proposal Ryan CordsenNovember 16, 2016
No-Action Letter for BlackRock, Inc. Did Not Permit Exclusion of Executive Compensation Proxy Voting Practices Proposal Nicole JonesNovember 16, 2016
